UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-7 of 7 Help

Filters            
Selected(0)Clear Items/Page:    Sort:
Monitoring drug research on clinical neurology in China: An analysis of institutional leaders and community themes Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 53-72
Authors:  Ka Weng Si Tou;  Jianbo Wan;  Marvin S.H. Mak;  Yifan Han;  Yuanjia Hu
Favorite  |  View/Download:3/0  |  Submit date:2019/01/14
Neurological Drugs  Thematic Analysis  Greater China  Publications  Research Collaboration Networks  
An analysis of evolutionary conservation based on genomic orthology and protein-protein interaction networks Book chapter
出自: Biotechnology in Hong Kong Volume III, Whitestone, New York:United State-China Itelletual Property Institute Inc, 2017, 页码: 49-60
Authors:  Hui Hens Lin;  Pengpeng Li;  Xiangjun Kong;  Jing Cai;  Shibing Su;  Yuanjia Hu;  Hui Hens Lin;  Pengpeng Li;  Xiangjun Kong;  Jing Cai;  Shibing Su;  Yuanjia Hu
Favorite  |  View/Download:6/0  |  Submit date:2019/01/14
Protein-protein Interaction Networks  Evolutionary Conservation  Orthologs  
Pharmaceutical innovation network: Global patterns and the role of China Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 259-281
Authors:  Pengpeng Li;  Huiheng Lin;  Yuanjia Hu
Favorite  |  View/Download:4/0  |  Submit date:2019/01/15
Pharmaceutical Innovation  Drug Patents  Network Analysis  
An analysis of technology flows of antidepressants based on patent citation network Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 187-208
Authors:  Siqi Tian;  Hui Heng Lin;  Marvin S.H. Mak;  Yifan Han;  Yuanjia Hu
Favorite  |  View/Download:3/0  |  Submit date:2019/01/14
China’s landscape of discovering miRNAs in cancer Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 73-90
Authors:  Hengwa Kuok;  Xiangjun Kong;  Yuanjia Hu;  Yitao Wang
Favorite  |  View/Download:4/0  |  Submit date:2019/01/14
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 135-158
Authors:  Tianhong Yin;  Xiangjun Kong;  Yitao Wang;  Xin Chen;  Yuanjia Hu;  Rong Shao
Favorite  |  View/Download:10/0  |  Submit date:2019/01/14
Monoclonal Antibodies  Research And Development  Network Analysis  Institutional Collaboration Network  Country-based Collaboration Network  
Discovering mirnas in cancer: China's landscape and the role of Hong Kong Book chapter
出自: Biotechnology in Hong Kong Volume II, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2015, 页码: 13-26
Authors:  Hengwa Kuok;  Xiangjun Kong;  Yuanjia Hu;  Yitao Wang
Favorite  |  View/Download:2/0  |  Submit date:2019/01/15